JP2020525253A - 絹−ヒアルロン酸系組織フィラー、及びそれを用いる方法 - Google Patents

絹−ヒアルロン酸系組織フィラー、及びそれを用いる方法 Download PDF

Info

Publication number
JP2020525253A
JP2020525253A JP2020520437A JP2020520437A JP2020525253A JP 2020525253 A JP2020525253 A JP 2020525253A JP 2020520437 A JP2020520437 A JP 2020520437A JP 2020520437 A JP2020520437 A JP 2020520437A JP 2020525253 A JP2020525253 A JP 2020525253A
Authority
JP
Japan
Prior art keywords
tissue filler
spf
silk
tissue
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020520437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020525253A5 (https=
Inventor
グレゴリー・エイチ・アルトマン
ペン・シュー
エルレイ・ジン
Original Assignee
エヴォルヴド バイ ネイチャー インコーポレーテッド
エヴォルヴド バイ ネイチャー インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エヴォルヴド バイ ネイチャー インコーポレーテッド, エヴォルヴド バイ ネイチャー インコーポレーテッド filed Critical エヴォルヴド バイ ネイチャー インコーポレーテッド
Publication of JP2020525253A publication Critical patent/JP2020525253A/ja
Publication of JP2020525253A5 publication Critical patent/JP2020525253A5/ja
Priority to JP2023122912A priority Critical patent/JP7660619B2/ja
Priority to JP2024192754A priority patent/JP2025020289A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2020520437A 2017-06-26 2018-06-26 絹−ヒアルロン酸系組織フィラー、及びそれを用いる方法 Pending JP2020525253A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023122912A JP7660619B2 (ja) 2017-06-26 2023-07-28 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法
JP2024192754A JP2025020289A (ja) 2017-06-26 2024-11-01 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762525131P 2017-06-26 2017-06-26
US62/525,131 2017-06-26
US201862641095P 2018-03-09 2018-03-09
US62/641,095 2018-03-09
PCT/US2018/039574 WO2019005848A1 (en) 2017-06-26 2018-06-26 HYALURONIC SILK ACID TISSUE FILLING AGENTS AND METHODS OF USE THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023122912A Division JP7660619B2 (ja) 2017-06-26 2023-07-28 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法

Publications (2)

Publication Number Publication Date
JP2020525253A true JP2020525253A (ja) 2020-08-27
JP2020525253A5 JP2020525253A5 (https=) 2021-08-12

Family

ID=64742709

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020520437A Pending JP2020525253A (ja) 2017-06-26 2018-06-26 絹−ヒアルロン酸系組織フィラー、及びそれを用いる方法
JP2023122912A Active JP7660619B2 (ja) 2017-06-26 2023-07-28 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法
JP2024192754A Pending JP2025020289A (ja) 2017-06-26 2024-11-01 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023122912A Active JP7660619B2 (ja) 2017-06-26 2023-07-28 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法
JP2024192754A Pending JP2025020289A (ja) 2017-06-26 2024-11-01 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法

Country Status (13)

Country Link
EP (2) EP4169539B1 (https=)
JP (3) JP2020525253A (https=)
KR (1) KR20200032103A (https=)
CN (1) CN111263646A (https=)
AU (2) AU2018290810C1 (https=)
CA (1) CA3068296A1 (https=)
CO (1) CO2020000774A2 (https=)
ES (2) ES2935887T3 (https=)
IL (2) IL299584A (https=)
MA (1) MA49520A (https=)
SG (1) SG11201913229PA (https=)
UA (1) UA127350C2 (https=)
WO (1) WO2019005848A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190997A1 (en) 2017-06-26 2023-06-22 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue filers and methods of using the same
JP6508431B1 (ja) 2017-09-21 2019-05-08 住友電気工業株式会社 半絶縁性ヒ化ガリウム結晶基板
AU2019405953B2 (en) * 2018-12-19 2025-09-18 Evolved By Nature, Inc. Silk-hyaluronic acid tissue fillers and methods of making and using the same
US20220193305A1 (en) * 2019-03-29 2022-06-23 Trustees Of Tufts College Crosslinked silk fibroin-based compositions, and methods of making and using the same
AU2020289479A1 (en) * 2019-06-06 2022-02-03 Evolved By Nature, Inc. Silk stimulated collagen production and methods of use thereof
WO2020262596A1 (en) * 2019-06-26 2020-12-30 Compagnie Generale Des Etablissements Michelin A noise improving tread
CN110339398A (zh) * 2019-07-18 2019-10-18 王月玲 一种含氨基酸透明质酸钠注射剂及其制备方法
EP4017537A4 (en) * 2019-08-20 2023-08-16 Evolved by Nature, Inc. SILK PERSONAL CARE PRODUCTS
EP3995530B1 (en) * 2019-09-27 2025-05-28 LG Chem, Ltd. A method of preparing polymer microparticles, polymer microparticles, medical composition, cosmetic composition, medical articles, and cosmetic articles using the same
PL4077402T3 (pl) * 2019-12-19 2024-07-29 Croma-Pharma Gmbh Kwas hialuronowy modyfikowany tiolem i hydrożel zawierający usieciowany kwas hialuronowy
CN116507315A (zh) * 2020-06-19 2023-07-28 自然进化公司 用于组织填充、组织间隔和组织膨胀的丝-透明质酸组合物
US20250295691A1 (en) * 2020-06-19 2025-09-25 Evolved By Nature, Inc. Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking
JP2024519426A (ja) * 2020-09-29 2024-05-14 ジロパ・インコーポレイテッド 疼痛の緩和及び麻痺のための組成物及び方法
TR202101065A1 (tr) * 2021-01-25 2022-08-22 Hacettepe Ueniversitesi Hyaluroni̇k asi̇t jel i̇çeren bi̇r doku dolgu malzemesi̇ ve üreti̇m yöntemi̇
CN114213517B (zh) * 2021-02-08 2024-07-09 复向丝泰医疗科技(苏州)有限公司 利用切向流超滤技术制备可控高浓度丝素蛋白溶液的方法
JP7695344B2 (ja) 2021-05-21 2025-06-18 ケンブリッジ クロップス インコーポレイテッド． ドゥーイングビジネスアズ モリ 絹フィブロイン溶液及び絹フィブロインを含む粉末を製造するためのシステム及び方法
WO2023275278A1 (en) * 2021-06-30 2023-01-05 Merz Pharma Gmbh & Co. Kgaa Hyaluronic acid dermal fillers crosslinked with polyethylene glycol diglycidyl ether, method for making same and uses thereof
CN113368220A (zh) * 2021-07-05 2021-09-10 云南维他源生物科技有限公司 一种ahco组合物及其制剂与应用
KR20230013682A (ko) 2021-07-16 2023-01-27 주식회사 휴메딕스 Pegde로 가교된 히알루론산 필러 및 이의 제조방법
US11864569B2 (en) 2021-08-16 2024-01-09 Cambridge Crops, Inc. Systems and methods for improving the performance of cereal using a silk fibroin solution and powders containing silk fibroin
CN114028610B (zh) * 2021-10-26 2022-10-25 北京诺康达医药科技股份有限公司 一种亲水性注射型皮肤填充组合物及其制备方法与应用
KR102766244B1 (ko) * 2024-02-16 2025-02-10 충남대학교 산학협력단 Lc-ms/ms 기반의 히알루론산, bdde 및 bdde 가교된 히알루론산의 정량방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189292A1 (en) * 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
JP2014515307A (ja) * 2011-06-03 2014-06-30 アラーガン、インコーポレイテッド 抗酸化物質を含む皮膚充填剤組成物
US20140315828A1 (en) * 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
JP2016531943A (ja) * 2013-09-30 2016-10-13 シルク セラピューティクス， インコーポレイテッド 絹タンパク質断片組成物及びそれから製造された物品
WO2018039496A1 (en) * 2016-08-24 2018-03-01 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH453269A4 (https=) 1968-03-29 1973-01-31
FR2334107A1 (fr) 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
US4355023A (en) 1980-09-30 1982-10-19 The Massachusetts General Hospital Antibody fragment compositions and process
US4657853A (en) 1984-09-14 1987-04-14 E. I. Du Pont De Nemours And Company Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2011059325A2 (en) * 2009-11-11 2011-05-19 University Of Twente, Institute For Biomedical Technology And Technical Medicine (Mira) Dextran-hyaluronic acid based hydrogels
CN108379112A (zh) * 2011-09-14 2018-08-10 阿勒根公司 用于细纹治疗的真皮填充剂组合物
CN102836465B (zh) * 2012-08-30 2014-06-04 浙江星月生物科技股份有限公司 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用
WO2014055895A1 (en) * 2012-10-05 2014-04-10 Allergan, Inc. Injectable device and method for sculpting, augmenting or correcting facial features such as the chin
HK1224315A1 (zh) 2013-06-28 2017-08-18 Galderma S.A. 用於制备交联的透明质酸产物的方法
EA035551B1 (ru) 2014-12-02 2020-07-06 Силк Терапьютикс, Инк. Изделие
MX2017013949A (es) * 2015-04-29 2018-11-09 Silk Therapeutics Inc Composiciones mectantes a base de seda y sus metodos.
US10175996B2 (en) 2016-05-02 2019-01-08 Norman R. Byrne Information display and control for work areas

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189292A1 (en) * 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
JP2014515307A (ja) * 2011-06-03 2014-06-30 アラーガン、インコーポレイテッド 抗酸化物質を含む皮膚充填剤組成物
US20140315828A1 (en) * 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
JP2016531943A (ja) * 2013-09-30 2016-10-13 シルク セラピューティクス， インコーポレイテッド 絹タンパク質断片組成物及びそれから製造された物品
WO2018039496A1 (en) * 2016-08-24 2018-03-01 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation

Also Published As

Publication number Publication date
EP4169539A1 (en) 2023-04-26
AU2024219582A1 (en) 2024-10-03
ES2935887T3 (es) 2023-03-13
AU2018290810C1 (en) 2024-09-12
US20230338614A1 (en) 2023-10-26
UA127350C2 (uk) 2023-07-26
JP2025020289A (ja) 2025-02-12
EP3645063A4 (en) 2021-04-14
EP4169539B1 (en) 2025-01-29
EP4169539C0 (en) 2025-01-29
JP2023139249A (ja) 2023-10-03
WO2019005848A1 (en) 2019-01-03
KR20200032103A (ko) 2020-03-25
AU2018290810B2 (en) 2024-06-13
JP7660619B2 (ja) 2025-04-11
EP3645063A1 (en) 2020-05-06
CN111263646A (zh) 2020-06-09
CA3068296A1 (en) 2019-01-03
CO2020000774A2 (es) 2020-05-05
IL299584A (en) 2023-03-01
SG11201913229PA (en) 2020-01-30
IL271692B2 (en) 2023-06-01
ES3018883T3 (en) 2025-05-19
IL271692A (en) 2020-02-27
EP3645063B1 (en) 2022-09-28
MA49520A (fr) 2021-04-14
AU2018290810A1 (en) 2020-02-13
BR112019027687A2 (pt) 2020-09-15

Similar Documents

Publication Publication Date Title
JP7660619B2 (ja) 絹－ヒアルロン酸系組織フィラー、及びそれを用いる方法
US20250332322A1 (en) Silk-hyaluronic acid tissue fillers and methods of making and using the same
US11660372B2 (en) Silk-hyaluronic acid based tissue fillers and methods of using the same
US20250295691A1 (en) Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking
US12611484B2 (en) Silk-hyaluronic acid based tissue filers and methods of using the same
HK40031640A (en) Silk-hyaluronic acid based tissue fillers and methods of using the same
HK40091189B (en) Silk-hyaluronic acid based tissue fillers and methods of using the same
HK40091189A (en) Silk-hyaluronic acid based tissue fillers and methods of using the same
HK40064387A (en) Silk-hyaluronic acid tissue fillers and methods of making and using the same
EA045185B1 (ru) Тканевые филлеры на основе шелка и гиалуроновой кислоты и способы их применения
HK40030280A (en) Silk-hyaluronic acid based tissue fillers and methods of using the same
HK40030280B (en) Silk-hyaluronic acid based tissue fillers and methods of using the same
BR112019027687B1 (pt) Enchimento de tecido biocompatível e uso de um enchimento de tecido

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210624

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20220527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220726

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221220

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230728

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230913

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20231020

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20241121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241121

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20241129

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251120

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260116